Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
BMC Cell Biol ; 15: 25, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24986648

ABSTRACT

BACKGROUND: Nuclear Dbf-related/large tumor suppressor (NDR/LATS) kinases have been shown recently to control pathways that regulate mitotic exit, cytokinesis, cell growth, morphological changes and apoptosis. LATS kinases are core components of the Hippo signaling cascade and important tumor suppressors controlling cell proliferation and organ size in flies and mammals, and homologs are also present in yeast and Dictyostelium discoideum. Ras proto-oncogens regulate many biological functions, including differentiation, proliferation and apoptosis. Dysfunctions of LATS kinases or Ras GTPases have been implicated in the development of a variety of cancers in humans. RESULTS: In this study we used the model organism Dictyostelium discoideum to analyze the functions of NdrC, a homolog of the mammalian LATS2 protein, and present a novel regulatory mechanism for this kinase. Deletion of the ndrC gene caused impaired cell division and loss of centrosome integrity. A yeast two-hybrid analysis, using activated Ras proteins as bait, revealed NdrC as an interactor and identified its Ras-binding domain. Further in vitro pull-down assays showed that NdrC binds RasG and RasB, and to a lesser extent RasC and Rap1. In cells lacking NdrC, the levels of activated RasB and RasG are up-regulated, suggesting a functional connection between RasB, RasG, and NdrC. CONCLUSIONS: Dictyostelium discoideum NdrC is a LATS2-homologous kinase that is important for the regulation of cell division. NdrC contains a Ras-binding domain and interacts preferentially with RasB and RasG. Changed levels of both, RasB or RasG, have been shown previously to interfere with cell division. Since a defect in cell division is exhibited by NdrC-null cells, RasG-null cells, and cells overexpressing activated RasB, we propose a model for the regulation of cytokinesis by NdrC that involves the antagonistic control by RasB and RasG.


Subject(s)
Dictyostelium/cytology , Dictyostelium/enzymology , Protein Serine-Threonine Kinases/metabolism , Protozoan Proteins/metabolism , Tumor Suppressor Proteins/metabolism , ras Proteins/metabolism , Amino Acid Sequence , Animals , Cell Division , Dictyostelium/chemistry , Humans , Molecular Sequence Data , Protein Serine-Threonine Kinases/analysis , Protozoan Proteins/analysis , Signal Transduction , Tumor Suppressor Proteins/analysis , ras Proteins/analysis
2.
Traffic ; 12(3): 301-12, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21134080

ABSTRACT

Dictyostelium discoideum cells are professional phagocytes that provide an easily accessible system to gain insights into the mechanisms and the regulatory machinery controlling phagocytosis. Here, we describe a novel function for nuclear Dbf2-related (NDR) family kinases in phagocytosis of D. discoideum. Deletion of one of the four NDR kinases of D. discoideum, NdrA, resulted in impaired cell growth caused by reduced phagocytosis rates. Detailed analysis of NdrA-null cells revealed that the formation of phagocytic cups was delayed. Microscopic investigations showed that NdrA localizes to centrosomes, and NdrA was also identified in isolated centrosome preparations. The localization of NdrA is regulated during the cell cycle. In prophase, NdrA disappears from the centrosome and forms a cloud-like structure around the spindle, which is totally absent during later stages until completion of mitosis. Our results suggest that a signal which originates from the NdrA kinase at the centrosome affects the efficiency of phagocytosis. We assume that in NdrA-null cells the defects in phagocytosis may be caused by an impairment of vesicle trafficking, which is involved in providing new membrane at the sites of particle uptake.


Subject(s)
Dictyostelium/enzymology , Phagocytosis/physiology , Protein Serine-Threonine Kinases/metabolism , Protozoan Proteins/metabolism , Cell Cycle/physiology , Centrosome/enzymology , Dictyostelium/genetics , Fluorescent Antibody Technique , Gene Expression Regulation, Enzymologic , Phagocytosis/genetics , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/genetics , Protein Transport , Protozoan Proteins/genetics
3.
Sci Rep ; 12(1): 1680, 2022 01 31.
Article in English | MEDLINE | ID: mdl-35102265

ABSTRACT

Biomarkers may help to improve our knowledge about the complex pathophysiology of atrial fibrillation (AF). In this study we sought to identify significant changes in biomarkers and clinical measures in patients with and without AF recurrence after electrical cardioversion. We measured 21 conventional and new biomarkers before and 30 days after electrical cardioversion and assessed the associations of changes in biomarker levels with rhythm status at follow-up. Significant between-group changes were observed for bone morphogenetic protein 10 (BMP10), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and total bilirubin. Their respective changes were - 10.4%, - 62.0% and - 25.6% in patients with sinus rhythm, and 3.1%, 1.1% and - 9.4% in patients with recurrent AF, for a between-group difference of - 13.5% (95% confidence interval [CI] - 19.3% to - 7.6%; P < 0.001), - 63.1% (95% CI - 76.6% to - 49.6%; P < 0.001) and - 16.3% (95% CI - 27.9% to - 4.7%; P = 0.007). In multivariable models, the reductions of BMP10 and NT-proBNP were significantly associated with follow-up rhythm status (ß coefficient per 1 - SD decrease, - 3.85; 95% CI - 6.34 to - 1.35; P = 0.003 for BMP10 and - 5.84; 95% CI - 10.22 to - 1.47; P = 0.009 for NT-proBNP. In conclusion, changes in BMP10 und NT-proBNP levels were independently associated with rhythm status after cardioversion, suggesting that these markers may be dependent on the actual heart rhythm.


Subject(s)
Atrial Fibrillation/therapy , Bilirubin/blood , Bone Morphogenetic Proteins/blood , Electric Countershock , Heart Conduction System/physiopathology , Heart Rate , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Action Potentials , Aged , Atrial Fibrillation/blood , Atrial Fibrillation/diagnosis , Atrial Fibrillation/physiopathology , Biomarkers/blood , Electric Countershock/adverse effects , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Recovery of Function , Recurrence , Time Factors , Treatment Outcome
4.
Cell Motil Cytoskeleton ; 66(11): 929-39, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19479821

ABSTRACT

During a REMI screen for proteins regulating cytokinesis in Dictyostelium discoideum we isolated a mutant forming multinucleate cells. The gene affected in this mutant encoded a kinase, SepA, which is an ortholog of Cdc7, a serine-threonine kinase essential for septum formation in Schizosaccharomyces pombe. Localization of SepA-GFP in live cells and its presence in isolated centrosomes indicated that SepA, like its upstream regulator Spg1, is associated with centrosomes. Knockout mutants of SepA showed a severe cytokinesis defect and a delay in development. In multinucleate SepA-null cells nuclear division proceeded normally and synchronously. However, often cleavage furrows were either missing or atypical: they were extremely asymmetric and constriction was impaired. Cortexillin-I, a marker localizing strictly to the furrow in wild-type cells, demonstrated that large, crescent-shaped furrows expanded and persisted long after the spindle regressed and nuclei returned to the interphase state. Outside the furrow the filamentous actin system of the cell cortex showed strong ruffling activity. These data suggest that SepA is involved in the spatial and temporal control system organizing cortical activities in mitotic and postmitotic cells.


Subject(s)
Cytokinesis/physiology , Dictyostelium/ultrastructure , Protein Serine-Threonine Kinases/metabolism , Actins/metabolism , Actins/ultrastructure , Animals , Cell Cycle Proteins/genetics , Cell Surface Extensions/ultrastructure , Centrosome/metabolism , Centrosome/ultrastructure , Dictyostelium/chemistry , Microscopy, Confocal , Protein Serine-Threonine Kinases/genetics , Schizosaccharomyces pombe Proteins/genetics , Spindle Apparatus/physiology , Spindle Apparatus/ultrastructure
5.
JCI Insight ; 5(16)2020 08 20.
Article in English | MEDLINE | ID: mdl-32814717

ABSTRACT

BACKGROUNDGenomic and experimental studies suggest a role for PITX2 in atrial fibrillation (AF). To assess if this association is relevant for recurrent AF in patients, we tested whether left atrial PITX2 affects recurrent AF after AF ablation.METHODSmRNA concentrations of PITX2 and its cardiac isoform, PITX2c, were quantified in left atrial appendages (LAAs) from patients undergoing thoracoscopic AF ablation, either in whole LAA tissue (n = 83) or in LAA cardiomyocytes (n = 52), and combined with clinical parameters to predict AF recurrence. Literature suggests that BMP10 is a PITX2-repressed, atrial-specific, secreted protein. BMP10 plasma concentrations were combined with 11 cardiovascular biomarkers and clinical parameters to predict recurrent AF after catheter ablation in 359 patients.RESULTSReduced concentrations of cardiomyocyte PITX2, but not whole LAA tissue PITX2, were associated with AF recurrence after thoracoscopic AF ablation (16% decreased recurrence per 2-(ΔΔCt) increase in PITX2). RNA sequencing, quantitative PCR, and Western blotting confirmed that BMP10 is one of the most PITX2-repressed atrial genes. Left atrial size (HR per mm increase [95% CI], 1.055 [1.028, 1.082]); nonparoxysmal AF (HR 1.672 [1.206, 2.318]), and elevated BMP10 (HR 1.339 [CI 1.159, 1.546] per quartile increase) were predictive of recurrent AF. BMP10 outperformed 11 other cardiovascular biomarkers in predicting recurrent AF.CONCLUSIONSReduced left atrial cardiomyocyte PITX2 and elevated plasma concentrations of the PITX2-repressed, secreted atrial protein BMP10 identify patients at risk of recurrent AF after ablation.TRIAL REGISTRATIONClinicalTrials.gov NCT01091389, NL50069.018.14, Dutch National Registry of Clinical Research Projects EK494-16.FUNDINGBritish Heart Foundation, European Union (H2020), Leducq Foundation.


Subject(s)
Atrial Appendage/cytology , Atrial Fibrillation/etiology , Atrial Fibrillation/surgery , Bone Morphogenetic Proteins/blood , Homeodomain Proteins/metabolism , Transcription Factors/metabolism , Aged , Atrial Appendage/metabolism , Biomarkers/blood , Bone Morphogenetic Proteins/metabolism , Catheter Ablation , Female , Homeodomain Proteins/genetics , Humans , Male , Middle Aged , Myocytes, Cardiac/metabolism , Thoracoscopy , Transcription Factors/genetics , Homeobox Protein PITX2
SELECTION OF CITATIONS
SEARCH DETAIL